Image-Based Cytometer Overview
Cytometry is the study of computing the characters of cells. Aspects that can be calculated by using cytometer include cell count, cell shape and structure, cell size, cell cycle phase, DNA content etc. Image-based cytometry is the most traditional form of cytometry. Optical microscopy is used by statically imaging a large number of cells to operate image cytometers. Before analysis, cells are usually stained to increase contrast or to spot certain molecules by tagging these with fluorochromes (fluorescent chemical compound that can re-emit light on light excitation).
Market Size & Forecast
Image-based cytometer requirement is anticipated to boost owing to technological advancements and the growing utilization of image-based flow cytometers in research activities. The image based cytometer market is thus estimated to expand at a robust CAGR over the forecast period.
Trend towards precision medicine where each clinical trial is towards a specific cell is emerging. Clinical applications of image cytometry basically includes measurement of DNA content of whole nuclei in ovarian tumors; measurement of DNA content of nuclei in sections of brain tumor; and analysis of DNA distribution of nuclei in sections of oral leukoplakia. Image cytometry has been particularly useful in studies of embedded tissues in which the tissue architecture is important in identifying regions for measurement, in which there may be very few cells available for measurement, or in which the tissue is not suitable for dissociation. With escalating research activities and the possibility obtainable for the equipment related demand for image-based cytometer market is expected to propel. Furthermore, market players are intensifying their existence by developing a new technology or by expanding in emerging countries.On the basis of regional platform, global image based cytometers market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region.
Get more information on this report: Download Sample PDF
North America is estimated to remain the ruling region owing to eminent advancements in research and development field along with elevated technological developments through the years.
While Asia Pacific is expected to emerge as a fastest growing region due to growing expenditure by the government on R&D activities as well as rising technological advancements in the developed and developing countries of the region. These factors are expected to drive the image-based cytometer market of the region.
Our-in depth analysis of the Global image-based cytometer market includes the following segments:
- Commercial Organizations
- Clinical Testing Labs
Global image-based cytometer market is further classified on the basis of region as follows:
- North America (United States, Canada), Market size, Y-O-Y growth Market size, Y-O-Y growth & Opportunity Analysis, Future forecast & Opportunity Analysis
- Latin America (Brazil, Mexico, Argentina, Rest of LATAM), Market size, Y-O-Y growth, Future forecast & Opportunity Analysis
- Europe (U.K., Germany, France, Italy, Spain, Hungary, BENELUX (Belgium, Netherlands, Luxembourg), NORDIC (Norway, Denmark, Sweden, Finland), Poland, Russia, Rest of Europe), Market size, Y-O-Y growth, Future forecast & Opportunity Analysis
- Asia-Pacific (China, India, Japan, South Korea, Malaysia, Indonesia, Taiwan, Hong Kong, Australia, New Zealand, Rest of Asia-Pacific), Market size, Y-O-Y growth, Future forecast & Opportunity Analysis
- Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa), Market size, Y-O-Y growth, Future forecast & Opportunity Analysis
Growth Drivers & Challenges
Image-based cytometer requirement is estimated to increase owing to technological advancements, development of intuitive software, increasing use of image-based cytometer in clinical trials and the growing utilization of image-based flow cytometers in research activities. Rapid ‘userâ€friendly’ systems currently under development may increase the market growth of image-based cytometric systems. High throughput screening (high sample passage from input to output) is available in almost all the recent technologies introduced because of the rising trend towards precision medicine where each clinical trial is towards a particular cell. Thus cell analyzer is also developed that provide the researcher with multifunctional results of thousands of cells.
The main problem for the researchers is to access such technology which has cost constraints associated to buying antibodies.
Top Featured Companies Dominating The Market
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- ChemoMetec A/S
- Nexcelom Bioscience LLC.
- Vala Sciences Inc.
- Merck KGaA
- GE Healthcare
- Yokogawa Electric Corporation
- Thorlabs, Inc.